Compare PDSB & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | LOAN |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 38.8M |
| IPO Year | 2015 | 1999 |
| Metric | PDSB | LOAN |
|---|---|---|
| Price | $1.25 | $3.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 8.0M | 34.2K |
| Earning Date | 11-20-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 13.29% |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $8,666,307.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $3.31 |
| 52 Week High | $1.79 | $5.01 |
| Indicator | PDSB | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 37.34 |
| Support Level | $0.60 | $3.31 |
| Resistance Level | $1.32 | $4.50 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 48.74 | 25.00 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.